Prostatic Neoplasms - Therapy
Research News and Information

Saturday, November 21, 2009

Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.

13 Nov 2009 New treatment approaches are needed for hormone refractory prostate cancer. Oncolytic adenoviruses are promising anti-cancer agents, and their efficacy can be improved by combining with conventional therapies such as ionizing radiation. The aim of ... Read more...

Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.

13 Oct 2009 We previously reported that naive, tumor-specific CD8(+) (TcR-I) T cells transferred into prostate tumor-bearing mice traffic to the prostate where they become tolerized. We now report that TcR-I cells suppress the proliferation of naive T cells. ... Read more...

Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.

13 Oct 2009 Despite extensive research, the contribution of bone-marrow-derived endothelial progenitor cells (BM-EPC) to tumor angiogenesis remains controversial. In previous publications, the extent of incorporation of BM-EPCs into the endothelial cell (EC) ... Read more...

Latest indexed articles for 'Prostatic Neoplasms - Therapy'

These are the very latest articles for this heading:

• In reply to Dr. Lee: are prostate cancers created equal? 13 Nov 2009
• Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation. 13 Nov 2009
• Computerized utility assessment for cancer decision making: promises and pitfalls. 30 Oct 2009
• The index lesion and the origin of prostate cancer. 20 Oct 2009
• Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells. 13 Oct 2009
• Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. 13 Oct 2009
• Prostate cancer screening and surveillance. 12 Oct 2009
• Prostate cancer: a newly discovered route for testosterone to reach the prostate : Treatment by super-selective intraprostatic androgen deprivation. 29 Sep 2009
• High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. 29 Sep 2009
• First do no harm. 29 Sep 2009
• Prostate specific antigen best practice statement: 2009 update. 22 Sep 2009
• Screening for prostate cancer remains controversial. 22 Sep 2009
• Editorial comment. 14 Sep 2009
• Differing perceptions of quality of life in patients with prostate cancer and their doctors. 14 Sep 2009
• Outcomes of localized prostate cancer following conservative management. 14 Sep 2009
• Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter. 13 Sep 2009
• Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. 13 Sep 2009
• Localized prostate cancer: the battle of treatment options enters the larger arena. 30 Aug 2009
• Optimal therapy in localized prostate cancer: an unfolding story. 30 Aug 2009
• Controversies in the management of localized prostate cancer: after the rhetoric. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Prostatic Neoplasms'

Definition: Tumors or cancer of the PROSTATE.

Descriptor UI: D011471

Alternative terms: Prostatic Neoplasms; Neoplasms, Prostate; Neoplasm, Prostate; Prostate Neoplasm; Neoplasms, Prostatic; Neoplasm, Prostatic; Prostatic Neoplasm; Prostate Neoplasms; Prostate Cancer; Cancer, Prostate; Cancers, Prostate; Prostate Cancers; Cancer of the Prostate; Prostatic Cancer; Cancer, Prostatic; Cancers, Prostatic; Prostatic Cancers; Cancer of Prostate;

Related Mesh Headings: Prostatic Hyperplasia; Prostate-Specific Antigen;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.945.440.770; C12.294.260.750; C12.294.565.625; C12.758.409.750;

Technical Notes: coordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available